Fezolinetant (Veozah; Astellas Pharma) for Vasomotor Symptoms Due to Menopause

Veozah is an NK3 receptor antagonist indicated for the treatment of moderate to severe vasomotor symptoms due to menopause.

If you have a Hayes login, click here to view the full report on the Knowledge Center.